Abdülsamet Erden

2.2k total citations
166 papers, 1.2k citations indexed

About

Abdülsamet Erden is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Abdülsamet Erden has authored 166 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Rheumatology, 43 papers in Pulmonary and Respiratory Medicine and 31 papers in Immunology. Recurrent topics in Abdülsamet Erden's work include Systemic Lupus Erythematosus Research (28 papers), COVID-19 Clinical Research Studies (23 papers) and Vasculitis and related conditions (23 papers). Abdülsamet Erden is often cited by papers focused on Systemic Lupus Erythematosus Research (28 papers), COVID-19 Clinical Research Studies (23 papers) and Vasculitis and related conditions (23 papers). Abdülsamet Erden collaborates with scholars based in Türkiye, United States and Cambodia. Abdülsamet Erden's co-authors include Ömer Karadağ, Umut Kalyoncu, Berkan Armağan, Levent Kılıç, Sedat Kiraz, Hasan Mutlu, Ali Akdoğan, Şule Apraş Bilgen, İhsan Ertenli and Orhan Küçükşahin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Abdülsamet Erden

145 papers receiving 1.2k citations

Peers

Abdülsamet Erden
Abdülsamet Erden
Citations per year, relative to Abdülsamet Erden Abdülsamet Erden (= 1×) peers Keiichi Sumida

Countries citing papers authored by Abdülsamet Erden

Since Specialization
Citations

This map shows the geographic impact of Abdülsamet Erden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdülsamet Erden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdülsamet Erden more than expected).

Fields of papers citing papers by Abdülsamet Erden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdülsamet Erden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdülsamet Erden. The network helps show where Abdülsamet Erden may publish in the future.

Co-authorship network of co-authors of Abdülsamet Erden

This figure shows the co-authorship network connecting the top 25 collaborators of Abdülsamet Erden. A scholar is included among the top collaborators of Abdülsamet Erden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdülsamet Erden. Abdülsamet Erden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Güler, Aslıhan Avanoğlu, Hazan Karadeniz, Özlem Gülbahar, et al.. (2025). PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD. Biomarkers in Medicine. 19(9). 349–355. 1 indexed citations
2.
Karadeniz, Hazan, Murat Uçar, Aslıhan Avanoğlu Güler, et al.. (2023). Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study. Seminars in Arthritis and Rheumatism. 62. 152246–152246. 5 indexed citations
3.
Erden, Abdülsamet, et al.. (2023). Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis. Laboratory Medicine. 54(6). 646–651. 2 indexed citations
4.
Armağan, Berkan, Serdar Can Güven, Abdülsamet Erden, et al.. (2023). COVID‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab. International Journal of Rheumatic Diseases. 26(5). 930–937. 1 indexed citations
5.
Erden, Abdülsamet, Serdar Can Güven, Berkan Armağan, et al.. (2023). Ustekinumab in Enteropathic Arthritis. Immunotherapy. 15(8). 583–592. 4 indexed citations
6.
Erden, Abdülsamet, Serdar Can Güven, Berkan Armağan, et al.. (2023). Tofacitinib experience in patients with enteropathic arthritis. Immunotherapy. 15(8). 619–626. 2 indexed citations
7.
Güven, Serdar Can, Berkan Armağan, Kevser Gök, et al.. (2022). A single‐center COVID‐19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients. International Journal of Rheumatic Diseases. 25(7). 787–794. 4 indexed citations
9.
Armağan, Berkan, Serdar Can Güven, Abdülsamet Erden, et al.. (2022). Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center. Immunopharmacology and Immunotoxicology. 45(4). 395–401. 2 indexed citations
10.
Erden, Abdülsamet, Antonis Fanouriakis, Serdar Can Güven, et al.. (2022). Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Lara D. Veeken. 61(9). 3606–3613. 8 indexed citations
11.
Erden, Abdülsamet, et al.. (2022). Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study. International Journal of Rheumatic Diseases. 26(2). 292–297. 6 indexed citations
12.
Güven, Serdar Can, et al.. (2022). Restless leg syndrome and sleep quality in granulomatosis with polyangiitis. 14(3). 124–130. 1 indexed citations
13.
Erden, Abdülsamet, et al.. (2022). Clinical Course of Idiopathic Inflammatory Myopathies in the COVID-19 Pandemic: A single-center Experience. Future Virology. 17(8). 545–556. 2 indexed citations
14.
Omma, Ahmet, Abdülsamet Erden, Serdar Can Güven, et al.. (2022). Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients. The Journal of Infection in Developing Countries. 16(1). 25–31. 1 indexed citations
15.
Davutoğlu, Mehmet, et al.. (2021). Predictive Values of Biochemical Markers As Early Indicators for Severe COVID-19 Cases in Admission. Future Virology. 16(5). 353–367. 19 indexed citations
16.
Şan, İshak, Mehmet Davutoğlu, Abdülsamet Erden, et al.. (2021). Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(6). 2810–2821. 12 indexed citations
17.
Akdoğan, Ali, Abdülsamet Erden, Levent Kılıç, et al.. (2019). Capillaroscopic findings in Turkish Takayasu arteritis patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(5). 1303–1307. 3 indexed citations
18.
Omma, Ahmet, et al.. (2019). Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch‐Schönlein purpura). International Journal of Rheumatic Diseases. 22(10). 1920–1925. 8 indexed citations
19.
Karadağ, Ömer, Abdülsamet Erden, Yelda Bilginer, et al.. (2018). A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts. Rheumatology International. 38(10). 1833–1840. 13 indexed citations
20.
Avcı, Deniz, et al.. (2016). Effect of anterior uveitis in Behçet's disease on neutrophil to lymphocyte ratio. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026